Freyer G - Search Results

1

The prognostic value of etoposide area under the curve (AUC) at first chemotherapy cycle in small cell lung cancer patients: a multicenter study of the groupe Lyon-Saint-Etienne d'Oncologie Thoracique (GLOT).

Freyer G, Ligneau B, Tranchand B, Ardiet C, Souquet PJ, Court-Fortune I, Riou R, Rebattu P, Morignat E, Boissel JP, Trillet-Lenoir V, Girard P. Freyer G, et al. Lung Cancer. 2001 Feb-Mar;31(2-3):247-56. doi: 10.1016/s0169-5002(00)00174-4. Lung Cancer. 2001. PMID: 11165404 Clinical Trial.

2

[Cytotoxic chemotherapy in elderly patients: present and future].

Freyer G, Maire P, Ardiet C, Tranchand B, Droz JP. Freyer G, et al. Bull Cancer. 1995 Jul;82(7):531-40. Bull Cancer. 1995. PMID: 7549115 Review. French.

3

Quality of final care for terminal cancer patients in a comprehensive cancer centre from the point of view of patients' families.

Merrouche Y, Freyer G, Saltel P, Rebattu P. Merrouche Y, et al. Among authors: freyer g. Support Care Cancer. 1996 May;4(3):163-8. doi: 10.1007/BF01682335. Support Care Cancer. 1996. PMID: 8739647

4

[Chemotherapy in elderly patients with bronchogenic cancers].

Souquet PJ, Lombard-Bohas CH, Freyer G, Bombaron P, Gerinière L, Bernard JP. Souquet PJ, et al. Among authors: freyer g. Rev Mal Respir. 1996;13(4):327-33. Rev Mal Respir. 1996. PMID: 8927787 Review. French.

5

[Adjuvant treatment of colonic cancers].

Freyer G, Descos L, Trillet-Lenoir V, Chang DH, Gérard JP. Freyer G, et al. Presse Med. 1996 Sep 21;25(27):1241-6. Presse Med. 1996. PMID: 8949736 Review. French.

6

[Neurosarcoma associated with neurofibromatosis 1. Apropos of a case and review of the literature].

Ligneau B, Freyer G, Giraud S, Isaac S, Bombaron P, Espinouse D, Plauchu H, Fischer G, Gérard JP, Lenoir G, Trillet-Lenoir V. Ligneau B, et al. Among authors: freyer g. Presse Med. 1997 Mar 29;26(10):458-63. Presse Med. 1997. PMID: 9137367 Review. French.

7

Pharmacokinetic studies in cancer chemotherapy: usefulness in clinical practice.

Freyer G, Ligneau B, Tranchand B, Ardiet C, Serre-Debeauvais F, Trillet-Lenoir V. Freyer G, et al. Cancer Treat Rev. 1997 May;23(3):153-69. doi: 10.1016/s0305-7372(97)90036-0. Cancer Treat Rev. 1997. PMID: 9251720 Review. No abstract available.

8

[Advantage of using tumor markers in colorectal and breast cancers. Guidelines of the American Society of Clinical Oncology (ASCO)].

Trillet-Lenoir V, Freyer G. Trillet-Lenoir V, et al. Among authors: freyer g. Bull Cancer. 1997 Jul;84(7):767-8. Bull Cancer. 1997. PMID: 9339206 French. No abstract available.

9

Colony-stimulating factors in the prevention of solid tumors induced by chemotherapy in patients with febrile neutropenia.

Freyer G, Ligneau B, Trillet-Lenoir V. Freyer G, et al. Int J Antimicrob Agents. 1998 Apr;10(1):3-9. doi: 10.1016/s0924-8579(98)00016-8. Int J Antimicrob Agents. 1998. PMID: 9624538 Review.

10

[Management of nonresectable non-small cell lung cancer. Recommendations of the American Society of Clinical Oncology (ASCO)].

Bompas E, Freyer G, Trillet-Lenoir V. Bompas E, et al. Among authors: freyer g. Bull Cancer. 1998 Feb;85(2):125-7. Bull Cancer. 1998. PMID: 9752328 Free article. French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

271 results

Search Page

Filters